| ENSG00000118412.8 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019827763 |
Resistant |
| ENSG00000179818.9 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027722019 |
Resistant |
| ENSG00000203325.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046352749 |
Resistant |
| ENSG00000204272.6 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037349931 |
Resistant |
| ENSG00000213971.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026061863 |
Resistant |
| ENSG00000214353.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043936384 |
Resistant |
| ENSG00000214401.4 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03448177 |
Resistant |
| ENSG00000223573.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049593047 |
Resistant |
| ENSG00000223660.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028726993 |
Resistant |
| ENSG00000224905.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029821586 |
Resistant |
| ENSG00000224992.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044632348 |
Resistant |
| ENSG00000225187.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047774912 |
Resistant |
| ENSG00000227388.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042508288 |
Resistant |
| ENSG00000228005.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029137461 |
Resistant |
| ENSG00000229915.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016720916 |
Resistant |
| ENSG00000231025.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048169961 |
Resistant |
| ENSG00000231327.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03175837 |
Resistant |
| ENSG00000231903.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041769175 |
Resistant |
| ENSG00000232342.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038961003 |
Resistant |
| ENSG00000234327.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046783493 |
Resistant |
| ENSG00000234753.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032216617 |
Resistant |
| ENSG00000235880.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025407398 |
Resistant |
| ENSG00000236498.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045088272 |
Resistant |
| ENSG00000237331.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031354611 |
Resistant |
| ENSG00000237359.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011057803 |
Resistant |
| ENSG00000237976.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024405015 |
Resistant |
| ENSG00000239335.4 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032279711 |
Resistant |
| ENSG00000240758.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012389384 |
Resistant |
| ENSG00000249492.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036972311 |
Resistant |
| ENSG00000250027.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036402891 |
Resistant |
| ENSG00000251405.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021212486 |
Resistant |
| ENSG00000253476.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031300478 |
Resistant |
| ENSG00000255989.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003622771 |
Resistant |
| ENSG00000257563.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039152348 |
Resistant |
| ENSG00000258285.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015946158 |
Resistant |
| ENSG00000258354.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031189843 |
Resistant |
| ENSG00000258378.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044439133 |
Resistant |
| ENSG00000258704.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035989158 |
Resistant |
| ENSG00000259209.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017221713 |
Resistant |
| ENSG00000259396.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023869533 |
Resistant |
| ENSG00000259548.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019827623 |
Resistant |
| ENSG00000259768.3 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005166643 |
Resistant |
| ENSG00000259901.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003249436 |
Resistant |
| ENSG00000259999.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044034915 |
Resistant |
| ENSG00000260447.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002333123 |
Resistant |
| ENSG00000260661.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037265987 |
Resistant |
| ENSG00000261000.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047929917 |
Resistant |
| ENSG00000261254.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018370517 |
Resistant |
| ENSG00000261673.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018010114 |
Resistant |
| ENSG00000261697.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047398789 |
Resistant |
| ENSG00000263499.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02724354 |
Resistant |
| ENSG00000263727.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011106318 |
Resistant |
| ENSG00000264895.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036869942 |
Resistant |
| ENSG00000265148.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025475783 |
Resistant |
| ENSG00000266579.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00116754 |
Resistant |
| ENSG00000266801.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009051534 |
Resistant |
| ENSG00000267212.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044578001 |
Resistant |
| ENSG00000267474.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047579167 |
Resistant |
| ENSG00000267575.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039176108 |
Resistant |
| ENSG00000267730.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015387094 |
Resistant |
| ENSG00000268201.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035406798 |
Resistant |
| ENSG00000268289.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029359539 |
Resistant |
| ENSG00000268516.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033704608 |
Resistant |
| ENSG00000268536.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025963462 |
Resistant |
| ENSG00000269107.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029425249 |
Resistant |
| ENSG00000270159.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007870702 |
Resistant |
| ENSG00000271119.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030039639 |
Resistant |
| ENSG00000271204.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031046978 |
Resistant |
| ENSG00000271882.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037307842 |
Resistant |
| ENSG00000272144.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048110272 |
Resistant |
| ENSG00000272308.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036500155 |
Resistant |
| ENSG00000272354.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009982897 |
Resistant |
| ENSG00000272382.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012065319 |
Resistant |
| ENSG00000272800.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018594589 |
Resistant |
| ENSG00000215498.4 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.036636557 |
Resistant |
| ENSG00000223635.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.019118067 |
Resistant |
| ENSG00000224857.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.016581192 |
Resistant |
| ENSG00000227486.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.035210893 |
Resistant |
| ENSG00000228857.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.045846304 |
Resistant |
| ENSG00000232656.3 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.016472761 |
Resistant |
| ENSG00000233554.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.039374366 |
Resistant |
| ENSG00000237301.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.020053808 |
Resistant |
| ENSG00000239569.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.044928831 |
Resistant |
| ENSG00000241481.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.047650671 |
Resistant |
| ENSG00000251175.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.040351793 |
Resistant |
| ENSG00000254910.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.049250571 |
Resistant |
| ENSG00000257135.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.034691001 |
Resistant |
| ENSG00000257526.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.015260192 |
Resistant |
| ENSG00000258181.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.041445616 |
Resistant |
| ENSG00000258777.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.020561225 |
Resistant |
| ENSG00000259153.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.032637728 |
Resistant |
| ENSG00000259673.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.035710303 |
Resistant |
| ENSG00000259920.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.044793536 |
Resistant |
| ENSG00000260006.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.006990073 |
Resistant |
| ENSG00000260920.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.023183577 |
Resistant |
| ENSG00000261135.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.017676826 |
Resistant |
| ENSG00000261173.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.009072792 |
Resistant |
| ENSG00000261441.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.028085287 |
Resistant |
| ENSG00000264043.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.046196136 |
Resistant |
| ENSG00000265458.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.047406749 |
Resistant |
| ENSG00000268530.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.028818698 |
Resistant |
| ENSG00000269423.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.028767982 |
Resistant |
| ENSG00000270009.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.037353046 |
Resistant |
| ENSG00000270066.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.049837226 |
Resistant |
| ENSG00000270091.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.022189778 |
Resistant |
| ENSG00000271344.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.027954174 |
Resistant |
| ENSG00000272366.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.042983731 |
Resistant |
| ENSG00000272576.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.031652667 |
Resistant |
| ENSG00000272662.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.02893178 |
Resistant |
| ENSG00000272911.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.038938931 |
Resistant |
| ENSG00000273399.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.032256578 |
Resistant |
| ENSG00000223695.1 |
Sorafenib |
Brain lower grade glioma |
0.04192444 |
Resistant |
| ENSG00000224142.1 |
Sorafenib |
Brain lower grade glioma |
0.04483132 |
Resistant |
| ENSG00000224281.4 |
Sorafenib |
Brain lower grade glioma |
0.048732449 |
Resistant |
| ENSG00000224950.1 |
Sorafenib |
Brain lower grade glioma |
0.012432617 |
Resistant |
| ENSG00000225140.1 |
Sorafenib |
Brain lower grade glioma |
0.03724133 |
Resistant |
| ENSG00000225857.1 |
Sorafenib |
Brain lower grade glioma |
0.006088037 |
Resistant |
| ENSG00000228838.1 |
Sorafenib |
Brain lower grade glioma |
0.036332478 |
Resistant |
| ENSG00000229642.1 |
Sorafenib |
Brain lower grade glioma |
0.030349487 |
Resistant |
| ENSG00000231010.1 |
Sorafenib |
Brain lower grade glioma |
0.002782129 |
Resistant |
| ENSG00000232411.1 |
Sorafenib |
Brain lower grade glioma |
0.007114233 |
Resistant |
| ENSG00000233029.3 |
Sorafenib |
Brain lower grade glioma |
0.000606582 |
Resistant |
| ENSG00000233895.1 |
Sorafenib |
Brain lower grade glioma |
0.034061936 |
Resistant |
| ENSG00000234571.1 |
Sorafenib |
Brain lower grade glioma |
0.005633687 |
Resistant |
| ENSG00000236137.1 |
Sorafenib |
Brain lower grade glioma |
0.028967403 |
Resistant |
| ENSG00000240254.1 |
Sorafenib |
Brain lower grade glioma |
0.0201391 |
Resistant |
| ENSG00000241886.1 |
Sorafenib |
Brain lower grade glioma |
0.032919162 |
Resistant |
| ENSG00000243055.1 |
Sorafenib |
Brain lower grade glioma |
0.001720021 |
Resistant |
| ENSG00000244380.1 |
Sorafenib |
Brain lower grade glioma |
0.01046973 |
Resistant |
| ENSG00000245080.4 |
Sorafenib |
Brain lower grade glioma |
0.000448974 |
Resistant |
| ENSG00000248243.1 |
Sorafenib |
Brain lower grade glioma |
0.012967998 |
Resistant |
| ENSG00000248516.1 |
Sorafenib |
Brain lower grade glioma |
0.040461496 |
Resistant |
| ENSG00000250075.1 |
Sorafenib |
Brain lower grade glioma |
0.013405336 |
Resistant |
| ENSG00000250751.1 |
Sorafenib |
Brain lower grade glioma |
0.036018263 |
Resistant |
| ENSG00000253167.1 |
Sorafenib |
Brain lower grade glioma |
0.04353657 |
Resistant |
| ENSG00000253636.1 |
Sorafenib |
Brain lower grade glioma |
0.028525823 |
Resistant |
| ENSG00000254419.1 |
Sorafenib |
Brain lower grade glioma |
0.038166892 |
Resistant |
| ENSG00000255395.1 |
Sorafenib |
Brain lower grade glioma |
0.021411318 |
Resistant |
| ENSG00000256690.1 |
Sorafenib |
Brain lower grade glioma |
0.029674874 |
Resistant |
| ENSG00000256789.1 |
Sorafenib |
Brain lower grade glioma |
0.039530029 |
Resistant |
| ENSG00000257354.1 |
Sorafenib |
Brain lower grade glioma |
0.003764998 |
Resistant |
| ENSG00000259353.1 |
Sorafenib |
Brain lower grade glioma |
0.025439842 |
Resistant |
| ENSG00000259709.1 |
Sorafenib |
Brain lower grade glioma |
0.014445547 |
Resistant |
| ENSG00000259969.1 |
Sorafenib |
Brain lower grade glioma |
0.037982405 |
Resistant |
| ENSG00000260132.1 |
Sorafenib |
Brain lower grade glioma |
0.03880523 |
Resistant |
| ENSG00000260278.1 |
Sorafenib |
Brain lower grade glioma |
0.036677618 |
Resistant |
| ENSG00000260392.1 |
Sorafenib |
Brain lower grade glioma |
0.000666041 |
Resistant |
| ENSG00000260625.1 |
Sorafenib |
Brain lower grade glioma |
0.016277945 |
Resistant |
| ENSG00000261220.2 |
Sorafenib |
Brain lower grade glioma |
0.004823018 |
Resistant |
| ENSG00000261469.1 |
Sorafenib |
Brain lower grade glioma |
0.01484713 |
Resistant |
| ENSG00000265478.1 |
Sorafenib |
Brain lower grade glioma |
0.033512508 |
Resistant |
| ENSG00000265485.1 |
Sorafenib |
Brain lower grade glioma |
0.003252321 |
Resistant |
| ENSG00000265752.2 |
Sorafenib |
Brain lower grade glioma |
0.038384768 |
Resistant |
| ENSG00000266803.1 |
Sorafenib |
Brain lower grade glioma |
0.016047422 |
Resistant |
| ENSG00000266824.1 |
Sorafenib |
Brain lower grade glioma |
0.017993878 |
Resistant |
| ENSG00000266968.1 |
Sorafenib |
Brain lower grade glioma |
0.002280526 |
Resistant |
| ENSG00000266975.1 |
Sorafenib |
Brain lower grade glioma |
0.031746059 |
Resistant |
| ENSG00000266983.1 |
Sorafenib |
Brain lower grade glioma |
0.042163609 |
Resistant |
| ENSG00000268499.1 |
Sorafenib |
Brain lower grade glioma |
0.014059529 |
Resistant |
| ENSG00000270174.1 |
Sorafenib |
Brain lower grade glioma |
0.018172006 |
Resistant |
| ENSG00000272343.1 |
Sorafenib |
Brain lower grade glioma |
0.004964802 |
Resistant |
| ENSG00000177788.5 |
Sorafenib |
Lung squamous cell carcinoma |
0.003498857 |
Resistant |
| ENSG00000180139.10 |
Sorafenib |
Lung squamous cell carcinoma |
0.012387663 |
Resistant |
| ENSG00000206337.6 |
Sorafenib |
Lung squamous cell carcinoma |
0.025857555 |
Resistant |
| ENSG00000223598.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.018807341 |
Resistant |
| ENSG00000225077.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.020068342 |
Resistant |
| ENSG00000225092.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.021956528 |
Resistant |
| ENSG00000230925.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.005931168 |
Resistant |
| ENSG00000232828.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.017889603 |
Resistant |
| ENSG00000233547.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.011687321 |
Resistant |
| ENSG00000246582.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.03239851 |
Resistant |
| ENSG00000247498.5 |
Sorafenib |
Lung squamous cell carcinoma |
0.048767766 |
Resistant |
| ENSG00000248416.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.042057836 |
Resistant |
| ENSG00000248936.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.016551757 |
Resistant |
| ENSG00000250551.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.049763363 |
Resistant |
| ENSG00000250714.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.018391935 |
Resistant |
| ENSG00000251523.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.035230144 |
Resistant |
| ENSG00000253582.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.012663965 |
Resistant |
| ENSG00000253911.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.022655624 |
Resistant |
| ENSG00000253930.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.049057714 |
Resistant |
| ENSG00000254554.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.040635357 |
Resistant |
| ENSG00000256006.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.00977547 |
Resistant |
| ENSG00000257086.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.038306566 |
Resistant |
| ENSG00000259294.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.047916728 |
Resistant |
| ENSG00000259713.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.038765012 |
Resistant |
| ENSG00000259760.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.033753372 |
Resistant |
| ENSG00000265490.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.033346738 |
Resistant |
| ENSG00000267272.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.019368282 |
Resistant |
| ENSG00000271228.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.02337054 |
Resistant |
| ENSG00000271722.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.029201044 |
Resistant |
| ENSG00000271931.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.041175244 |
Resistant |
| ENSG00000272945.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.020892438 |
Resistant |
| ENSG00000223414.2 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03918494 |
Sensitive |
| ENSG00000237523.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02167602 |
Sensitive |
| ENSG00000250786.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036350022 |
Sensitive |
| ENSG00000254154.4 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014964066 |
Sensitive |
| ENSG00000272699.1 |
Sorafenib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030786587 |
Sensitive |
| ENSG00000118412.8 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.027190641 |
Sensitive |
| ENSG00000177337.3 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.02780473 |
Sensitive |
| ENSG00000183822.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.016606916 |
Sensitive |
| ENSG00000187156.4 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.00044475 |
Sensitive |
| ENSG00000224189.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.043546426 |
Sensitive |
| ENSG00000224635.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.039755189 |
Sensitive |
| ENSG00000228028.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.004599691 |
Sensitive |
| ENSG00000231329.3 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.030057115 |
Sensitive |
| ENSG00000237200.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.012739435 |
Sensitive |
| ENSG00000238133.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.016289547 |
Sensitive |
| ENSG00000239941.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.04316924 |
Sensitive |
| ENSG00000241577.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.042157961 |
Sensitive |
| ENSG00000241818.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.004605169 |
Sensitive |
| ENSG00000242474.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.003846547 |
Sensitive |
| ENSG00000244300.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.030554394 |
Sensitive |
| ENSG00000246263.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.042067244 |
Sensitive |
| ENSG00000250751.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.029622505 |
Sensitive |
| ENSG00000253476.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.031749684 |
Sensitive |
| ENSG00000253708.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.019691823 |
Sensitive |
| ENSG00000253911.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.007285982 |
Sensitive |
| ENSG00000255723.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.035651617 |
Sensitive |
| ENSG00000256250.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.008205508 |
Sensitive |
| ENSG00000256299.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.016475042 |
Sensitive |
| ENSG00000258268.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.025287408 |
Sensitive |
| ENSG00000258354.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.041284058 |
Sensitive |
| ENSG00000259188.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.030427204 |
Sensitive |
| ENSG00000259768.3 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.026383045 |
Sensitive |
| ENSG00000261280.2 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.047481206 |
Sensitive |
| ENSG00000261616.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.04888766 |
Sensitive |
| ENSG00000262171.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.035414988 |
Sensitive |
| ENSG00000263080.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.02183799 |
Sensitive |
| ENSG00000264769.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.049237537 |
Sensitive |
| ENSG00000265394.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.042664346 |
Sensitive |
| ENSG00000265490.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.019473403 |
Sensitive |
| ENSG00000265666.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.001104351 |
Sensitive |
| ENSG00000265791.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.035260673 |
Sensitive |
| ENSG00000267416.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.030076343 |
Sensitive |
| ENSG00000270015.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.003167217 |
Sensitive |
| ENSG00000270069.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.033064104 |
Sensitive |
| ENSG00000272446.1 |
Sorafenib |
Chronic Lymphocytic Leukemia |
0.047324522 |
Sensitive |
| ENSG00000214559.3 |
Sorafenib |
Brain lower grade glioma |
0.007192837 |
Sensitive |
| ENSG00000223461.1 |
Sorafenib |
Brain lower grade glioma |
0.049389084 |
Sensitive |
| ENSG00000226291.1 |
Sorafenib |
Brain lower grade glioma |
0.035322782 |
Sensitive |
| ENSG00000230074.1 |
Sorafenib |
Brain lower grade glioma |
0.049878257 |
Sensitive |
| ENSG00000232028.1 |
Sorafenib |
Brain lower grade glioma |
0.040682431 |
Sensitive |
| ENSG00000235410.1 |
Sorafenib |
Brain lower grade glioma |
0.027989591 |
Sensitive |
| ENSG00000243368.2 |
Sorafenib |
Brain lower grade glioma |
0.011245501 |
Sensitive |
| ENSG00000258303.1 |
Sorafenib |
Brain lower grade glioma |
0.004151762 |
Sensitive |
| ENSG00000264673.1 |
Sorafenib |
Brain lower grade glioma |
0.031460799 |
Sensitive |
| ENSG00000266473.1 |
Sorafenib |
Brain lower grade glioma |
0.0339819 |
Sensitive |
| ENSG00000268707.1 |
Sorafenib |
Brain lower grade glioma |
0.046246286 |
Sensitive |
| ENSG00000268895.1 |
Sorafenib |
Brain lower grade glioma |
0.042236698 |
Sensitive |
| ENSG00000271732.1 |
Sorafenib |
Brain lower grade glioma |
0.037040082 |
Sensitive |
| ENSG00000273018.1 |
Sorafenib |
Brain lower grade glioma |
0.013082366 |
Sensitive |
| ENSG00000167912.5 |
Sorafenib |
Lung squamous cell carcinoma |
0.041803385 |
Sensitive |
| ENSG00000203325.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.019060865 |
Sensitive |
| ENSG00000214347.5 |
Sorafenib |
Lung squamous cell carcinoma |
0.011579224 |
Sensitive |
| ENSG00000224037.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.018640766 |
Sensitive |
| ENSG00000225929.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.022176724 |
Sensitive |
| ENSG00000226752.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.007241405 |
Sensitive |
| ENSG00000226828.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.012171748 |
Sensitive |
| ENSG00000227492.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.006547385 |
Sensitive |
| ENSG00000227906.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.008765169 |
Sensitive |
| ENSG00000228865.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.038895091 |
Sensitive |
| ENSG00000228939.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.031305453 |
Sensitive |
| ENSG00000229267.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.021890347 |
Sensitive |
| ENSG00000229874.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.002719741 |
Sensitive |
| ENSG00000230506.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.00052328 |
Sensitive |
| ENSG00000230928.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.026097754 |
Sensitive |
| ENSG00000231310.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.048366093 |
Sensitive |
| ENSG00000231882.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.026155834 |
Sensitive |
| ENSG00000232063.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.022032077 |
Sensitive |
| ENSG00000232640.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.037470388 |
Sensitive |
| ENSG00000234215.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.03404362 |
Sensitive |
| ENSG00000235497.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.030858117 |
Sensitive |
| ENSG00000235586.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.01087881 |
Sensitive |
| ENSG00000236028.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.039181076 |
Sensitive |
| ENSG00000236859.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.005527751 |
Sensitive |
| ENSG00000237357.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.018465866 |
Sensitive |
| ENSG00000237436.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.021711313 |
Sensitive |
| ENSG00000237919.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.007479184 |
Sensitive |
| ENSG00000244952.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.035915545 |
Sensitive |
| ENSG00000245059.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.003522905 |
Sensitive |
| ENSG00000245614.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.023559244 |
Sensitive |
| ENSG00000247324.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.000373685 |
Sensitive |
| ENSG00000248445.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.048775221 |
Sensitive |
| ENSG00000248724.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.019335416 |
Sensitive |
| ENSG00000251164.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.032239121 |
Sensitive |
| ENSG00000253369.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.030656027 |
Sensitive |
| ENSG00000253513.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.003912715 |
Sensitive |
| ENSG00000255326.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.015490168 |
Sensitive |
| ENSG00000259345.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.042313863 |
Sensitive |
| ENSG00000259488.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.023101612 |
Sensitive |
| ENSG00000259635.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.030596915 |
Sensitive |
| ENSG00000259768.3 |
Sorafenib |
Lung squamous cell carcinoma |
0.00570606 |
Sensitive |
| ENSG00000259772.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.032963073 |
Sensitive |
| ENSG00000259877.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.00620564 |
Sensitive |
| ENSG00000259901.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.043568809 |
Sensitive |
| ENSG00000260572.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.038154396 |
Sensitive |
| ENSG00000260742.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.017682829 |
Sensitive |
| ENSG00000261839.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.019762917 |
Sensitive |
| ENSG00000263727.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.003004512 |
Sensitive |
| ENSG00000263753.2 |
Sorafenib |
Lung squamous cell carcinoma |
0.013474978 |
Sensitive |
| ENSG00000264196.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.023305856 |
Sensitive |
| ENSG00000264365.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.011888873 |
Sensitive |
| ENSG00000264860.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.044957903 |
Sensitive |
| ENSG00000266446.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.011942575 |
Sensitive |
| ENSG00000266456.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.005179115 |
Sensitive |
| ENSG00000266803.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.027289838 |
Sensitive |
| ENSG00000266916.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.01332589 |
Sensitive |
| ENSG00000266921.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.017530748 |
Sensitive |
| ENSG00000267374.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.015153362 |
Sensitive |
| ENSG00000267480.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.027696609 |
Sensitive |
| ENSG00000267499.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.021016343 |
Sensitive |
| ENSG00000269400.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.013293661 |
Sensitive |
| ENSG00000269938.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.037449539 |
Sensitive |
| ENSG00000271384.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.017159842 |
Sensitive |
| ENSG00000271882.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.037738147 |
Sensitive |
| ENSG00000272312.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.028110022 |
Sensitive |
| ENSG00000272525.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.028214425 |
Sensitive |
| ENSG00000272721.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.030461263 |
Sensitive |
| ENSG00000272791.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.015143089 |
Sensitive |
| ENSG00000272815.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.02649635 |
Sensitive |
| ENSG00000273061.1 |
Sorafenib |
Lung squamous cell carcinoma |
0.034742067 |
Sensitive |
